−0.007AUD
−5.78 MAUD
70.53 KAUD
1.06 B
About RESPIRI LIMITED
Sector
Industry
CEO
Marjan Mikel
Website
Headquarters
Melbourne
Founded
1987
ISIN
AU000000RSH4
FIGI
BBG000BX65N1
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. The firm operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RSH is 0.032 AUD — it has decreased by 3.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange RESPIRI LIMITED stocks are traded under the ticker RSH.
RESPIRI LIMITED is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
RSH stock is 6.25% volatile and has beta coefficient of −0.19. Check out the list of the most volatile stocks — is RESPIRI LIMITED there?
RESPIRI LIMITED revenue for the last quarter amounts to 140.50 K AUD despite the estimated figure of 1.60 M AUD. In the next quarter revenue is expected to reach 100.00 K AUD.
Yes, you can track RESPIRI LIMITED financials in yearly and quarterly reports right on TradingView.
RSH stock has fallen by 5.88% compared to the previous week, the month change is a 10.34% rise, over the last year RESPIRI LIMITED has showed a 38.46% decrease.
RSH net income for the last quarter is −3.19 M AUD, while the quarter before that showed −3.20 M AUD of net income which accounts for 0.32% change. Track more RESPIRI LIMITED financial stats to get the full picture.
Today RESPIRI LIMITED has the market capitalization of 34.98 M, it has increased by 21.43% over the last week.
No, RSH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RSH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESPIRI LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RESPIRI LIMITED technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RESPIRI LIMITED stock shows the neutral signal. See more of RESPIRI LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESPIRI LIMITED EBITDA is −6.76 M AUD, and current EBITDA margin is −8.90 K%. See more stats in RESPIRI LIMITED financial statements.